An Engineered SARS-CoV-2 S1 Glycoprotein Produced in Pichia pastoris as a Candidate Vaccine Antigen.
Saved in:
| Title: | An Engineered SARS-CoV-2 S1 Glycoprotein Produced in Pichia pastoris as a Candidate Vaccine Antigen. |
|---|---|
| Authors: | Majidi S; Department of Microbiology & Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran., Aghaiypour Kolyani K; Biotechnology Department, Behesht Aein Laboratory Complex (MABA), No 193 Jala Al Ahmad Avenue, Tehran, Iran. khosrow_ak@yahoo.com.; Department of Genomics and Genetic Engineering, Razi Vaccine and Serum Research Institute (RVSRI), Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran. khosrow_ak@yahoo.com., Akrami M; Science Department, Science Faculty, Tehran Central Branch, Islamic Azad University, Tehran, Iran., Dadar M; Biotechnology Department, Behesht Aein Laboratory Complex (MABA), No 193 Jala Al Ahmad Avenue, Tehran, Iran.; Department of Genomics and Genetic Engineering, Razi Vaccine and Serum Research Institute (RVSRI), Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran. |
| Source: | Molecular biotechnology [Mol Biotechnol] 2026 Feb; Vol. 68 (2), pp. 815-827. Date of Electronic Publication: 2025 Feb 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Switzerland NLM ID: 9423533 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0305 (Electronic) Linking ISSN: 10736085 NLM ISO Abbreviation: Mol Biotechnol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1559-0305 |
|---|---|
| DOI: | 10.1007/s12033-025-01409-5 |
